Apolipoproteins and liver parameters optimize cardiovascular disease risk-stratification in nonalcoholic fatty liver disease

Dig Liver Dis. 2022 Aug;54(8):1135-1136. doi: 10.1016/j.dld.2022.04.018. Epub 2022 May 23.

Authors

Arsalan Nadeem¹, Sumayya Umar²

Affiliations

¹ Department of Medicine, Allama Iqbal Medical College, Allama Shabbir Ahmad Usmani Road, Lahore, Punjab 54550, Pakistan. Electronic address: arsalannadeemh@gmail.com.
² Department of Medicine, Allama Iqbal Medical College, Allama Shabbir Ahmad Usmani Road, Lahore, Punjab 54550, Pakistan. Electronic address: sumayyaumar286@gmail.com.

PMID: 35614007
DOI: 10.1016/j.dld.2022.04.018

No abstract available

Keywords: Cardiovascular disease; Fibrosis; Homocysteine; Risk stratification; Trimethylamine N-oxide.

Publication types

Letter
Comment

MeSH terms

Apolipoproteins
Cardiovascular Diseases* / etiology
Cardiovascular Diseases* / pathology
Humans
Liver / pathology
Liver Cirrhosis / pathology
Non-alcoholic Fatty Liver Disease* / complications
Non-alcoholic Fatty Liver Disease* / pathology

Substances

Apolipoproteins